SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2025ACC: 0001415889-25-018748
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+7.54K
Net shares
Net buyer
$12.8K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.54K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.54K
Price / share
$1.70
Trade value
$12.82K
% of position
71.9%
6/30/2025
10.49K→18.03K
Total
Net shares
+7.54K
Net value
$12.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | A · Award | +7.54K | $1.70 | $12.82K | 71.9% | 10.49K | 18.03K |
| Total | +7.54K | $12.82K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20.88K
Total
20.88K indirect20.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.88K | Indirect |
| Total | 20.88K | 20.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported